In a satisfaction survey involving 424 women, a dietary supplement marketed as Estrovera was linked to reduced hot flashes, sleep disturbances, and severity of menopause symptoms.
 
The findings of the consumer survey were presented at the Menopause Society’s annual meeting.
 
Estrovera contains a standardized extract branded as Err 731, sourced from rhapontic rhubarb, which, according to previous research, has modulatory effects on estrogen receptors.
 
The mechanism is evidenced to relieve symptoms without elevating estrogen levels, according to the company.
 
According to lead author Nilima Desai, MPH, RD, “the survey results align with outcomes from numerous randomized controlled trials demonstrating Estrovera’s ability to significantly reduce hot flash frequency and menopause symptom severity scores compared to placebo.” 
 
Of the 424 women who purchased Estrovera and responded to the survey, 90% experienced fewer hot flashes, 71% had less sleep disruption, and 95% noticed mood improvements.
 
“Drawing upon over a decade of experience as a family medicine practitioner, I’ve consistently employed Estrovera in my clinical practice with remarkable success,” said Bridgette Briggs, MD. “This product has brought about a profound transformation in the lives of countless accomplished women navigating the menopausal transition. By alleviating hot flashes, improving sleep quality, uplifting mood, and enhancing cognitive function, Estrovera stands out as one of the most impactful contributors to improved well-being that I’ve encountered.”